BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1204 related articles for article (PubMed ID: 30126638)

  • 1. Leishmaniasis.
    Burza S; Croft SL; Boelaert M
    Lancet; 2018 Sep; 392(10151):951-970. PubMed ID: 30126638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous and mucocutaneous leishmaniasis: Clinical perspectives.
    Handler MZ; Patel PA; Kapila R; Al-Qubati Y; Schwartz RA
    J Am Acad Dermatol; 2015 Dec; 73(6):897-908; quiz 909-10. PubMed ID: 26568335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis in immunosuppressed individuals.
    van Griensven J; Carrillo E; López-Vélez R; Lynen L; Moreno J
    Clin Microbiol Infect; 2014 Apr; 20(4):286-99. PubMed ID: 24450618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmaniasis and poverty.
    Alvar J; Yactayo S; Bern C
    Trends Parasitol; 2006 Dec; 22(12):552-7. PubMed ID: 17023215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmaniasis chemotherapy--challenges and opportunities.
    Croft SL; Olliaro P
    Clin Microbiol Infect; 2011 Oct; 17(10):1478-83. PubMed ID: 21933306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmaniasis.
    Herwaldt BL
    Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis.
    Piscopo TV; Mallia Azzopardi C
    Postgrad Med J; 2007 Feb; 83(976):649-57. PubMed ID: 17396274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmaniasis: current situation and new perspectives.
    Desjeux P
    Comp Immunol Microbiol Infect Dis; 2004 Sep; 27(5):305-18. PubMed ID: 15225981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmaniasis: new insights from an old and neglected disease.
    Antinori S; Schifanella L; Corbellino M
    Eur J Clin Microbiol Infect Dis; 2012 Feb; 31(2):109-18. PubMed ID: 21533874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral and cutaneous leishmaniasis (report of 2 cases).
    Sener B; Ergüven S; Günalp A
    Cent Eur J Public Health; 1999 Feb; 7(1):8-9. PubMed ID: 10084013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.
    Monge-Maillo B; López-Vélez R
    Clin Infect Dis; 2015 May; 60(9):1398-404. PubMed ID: 25601455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the leishmaniases.
    World Health Organization
    World Health Organ Tech Rep Ser; 2010; (949):xii-xiii, 1-186, back cover. PubMed ID: 21485694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).
    Aronson N; Herwaldt BL; Libman M; Pearson R; Lopez-Velez R; Weina P; Carvalho E; Ephros M; Jeronimo S; Magill A
    Am J Trop Med Hyg; 2017 Jan; 96(1):24-45. PubMed ID: 27927991
    [No Abstract]   [Full Text] [Related]  

  • 16. Leishmaniasis in Malta and the Mediterranean basin.
    Fenech FF
    Ann Trop Med Parasitol; 1997 Oct; 91(7):747-53. PubMed ID: 9625930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
    Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
    Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
    Chappuis F; Sundar S; Hailu A; Ghalib H; Rijal S; Peeling RW; Alvar J; Boelaert M
    Nat Rev Microbiol; 2007 Nov; 5(11):873-82. PubMed ID: 17938629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-kala-azar dermal leishmaniasis in HIV-coinfected individuals: problems in diagnosis and treatment.
    Ramesh V; Avishek K; Salotra P
    Int J Dermatol; 2015 Jan; 54(1):116-20. PubMed ID: 25209701
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.